In addition, SUA/Cr still showed a significant association with NAFLD incidence after additional adjustment for ALT and AST (OR: 1.548, 95% CI: 1.018–2.352, P=0.041, Model 3). This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.